• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在心源性休克中,超重和肥胖者死亡率最低,而恶病质患者死亡率最高。

In Cardiogenic Shock, Overweight and Obesity Have the Lowest, Whereas Cachexia Has the Highest Mortality.

作者信息

Movahed Mohammad Reza, Mahalleh Mehrdad, Sadin Zahra, Hashemzadeh Mehrtash

机构信息

Department of Medicine, University of Arizona Sarver Heart Center, 1501 North Campbell Avenue, Tucson, AZ 85724, USA.

Department of Medicine, University of Arizona College of Medicine, Phoenix, AZ 85004, USA.

出版信息

J Clin Med. 2025 Jul 25;14(15):5275. doi: 10.3390/jcm14155275.

DOI:10.3390/jcm14155275
PMID:40806895
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12346888/
Abstract

The obesity paradox has been observed in patients with cardiovascular disease. The goal of this study was to evaluate whether obesity has a protective effect in patients presenting with cardiogenic shock. Using a large Nationwide Inpatient (NIS) sample database, we evaluated mortality in patients with cardiogenic shock based on weight categories in adults. A total of 843,020 patients over age 18 had a diagnosis of cardiogenic shock in the database. We found that overweight and obesity had the lowest mortality using univariate or multivariate analysis (overweight mortality of 20.66% vs. obesity mortality of 26.6% vs. 34.8% of normal weights). In contrast, cachexia was associated with the highest mortality in univariate analysis (cachexia 40.4%). Using multivariate analysis adjusting for age, baseline characteristics, and comorbidities, these relations remained unchanged (cachexia MVOR: 1.13; CI: 1.21-1.13; < 0.001; overweight MVOR: 0.52, CI: 0.43-0.65; < 0.001; obesity MVOR: 0.76, CI: 0.73-0.79; < 0.001). After multivariate adjustment, morbid obesity had similar mortality to patients with normal weight (morbid obesity MVOR: 0.99 CI 0.95-01.03; = 0.6) We observe a partial obesity paradox in patients with cardiogenic shock, showing that being overweight, followed by obesity, has the lowest mortality, whereas cachexia has the highest mortality despite multivariate adjustment.

摘要

肥胖悖论已在心血管疾病患者中被观察到。本研究的目的是评估肥胖在心源性休克患者中是否具有保护作用。利用一个大型的全国住院患者(NIS)样本数据库,我们根据成年人的体重类别评估了心源性休克患者的死亡率。该数据库中共有843020名18岁以上的患者被诊断为心源性休克。我们发现,使用单因素或多因素分析时,超重和肥胖患者的死亡率最低(超重患者死亡率为20.66%,肥胖患者死亡率为26.6%,正常体重患者死亡率为34.8%)。相比之下,在单因素分析中,恶病质与最高死亡率相关(恶病质为40.4%)。在对年龄、基线特征和合并症进行多因素分析调整后,这些关系保持不变(恶病质多因素调整风险比:1.13;可信区间:1.21 - 1.13;P < 0.001;超重多因素调整风险比:0.52,可信区间:0.43 - 0.65;P < 0.001;肥胖多因素调整风险比:0.76,可信区间:0.73 - 0.79;P < 0.001)。多因素调整后,病态肥胖患者的死亡率与正常体重患者相似(病态肥胖多因素调整风险比:0.99,可信区间:0.95 - 1.03;P = 0.6)。我们在心源性休克患者中观察到部分肥胖悖论,表明超重其次是肥胖的患者死亡率最低,而恶病质患者尽管经过多因素调整仍具有最高死亡率。

相似文献

1
In Cardiogenic Shock, Overweight and Obesity Have the Lowest, Whereas Cachexia Has the Highest Mortality.在心源性休克中,超重和肥胖者死亡率最低,而恶病质患者死亡率最高。
J Clin Med. 2025 Jul 25;14(15):5275. doi: 10.3390/jcm14155275.
2
Partial obesity paradox regarding mortality in patients hospitalized with diastolic or systolic heart failure.舒张性或收缩性心力衰竭住院患者死亡率方面的部分肥胖悖论。
Future Cardiol. 2025 Apr;21(5):283-290. doi: 10.1080/14796678.2025.2477421. Epub 2025 Mar 10.
3
Bodyweight affects mortality in an L-shape pattern in patients undergoing coronary bypass grafting.体重对接受冠状动脉搭桥手术的患者的死亡率呈L形影响模式。
Future Cardiol. 2025 Jan;21(1):9-14. doi: 10.1080/14796678.2024.2440247. Epub 2025 Jan 5.
4
Mortality With Impella Is Lowest in Overweight and Obese but Is Highest in Morbid Obesity.Impella治疗的死亡率在超重和肥胖患者中最低,但在病态肥胖患者中最高。
Artif Organs. 2025 Mar 21. doi: 10.1111/aor.15000.
5
Weight Categories Have no Impact on Mortality in Patients Treated with Extracorporeal Membrane Oxygenation (ECMO).体重类别对接受体外膜肺氧合(ECMO)治疗的患者的死亡率没有影响。
J Intensive Care Med. 2025 Jun 27:8850666251351574. doi: 10.1177/08850666251351574.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Hormonal contraceptives for contraception in overweight or obese women.超重或肥胖女性避孕用激素避孕药
Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4.
9
Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.6至11岁超重或肥胖儿童治疗中的饮食、身体活动及行为干预措施
Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD012651. doi: 10.1002/14651858.CD012651.
10
Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.肥胖症减肥干预措施以提高子宫内膜癌女性的生存率。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD012513. doi: 10.1002/14651858.CD012513.pub3.

本文引用的文献

1
Body Mass Index and Mortality in Cardiogenic Shock.体重指数与心源性休克患者的死亡率。
ASAIO J. 2024 Oct 1;70(10):885-891. doi: 10.1097/MAT.0000000000002194. Epub 2024 Mar 25.
2
Impact of the Obesity Paradox Between Sexes on In-Hospital Mortality in Cardiogenic Shock: A Retrospective Cohort Study.性别间肥胖悖论对心源性休克患者院内死亡率的影响:一项回顾性队列研究。
J Am Heart Assoc. 2022 Jun 7;11(11):e024143. doi: 10.1161/JAHA.121.024143. Epub 2022 Jun 6.
3
Association of Body Mass Index with Mortality in Patients with Cardiogenic Shock following Acute Myocardial Infarction: A Contemporary Danish Cohort Analysis.急性心肌梗死后心源性休克患者体重指数与死亡率的关联:一项当代丹麦队列分析
Cardiology. 2021;146(5):575-582. doi: 10.1159/000515063. Epub 2021 Jul 20.
4
Influence of Body Mass Index on the Management and Outcomes of Acute Myocardial Infarction-Cardiogenic Shock in the United States, 2008-2017.2008-2017 年美国体重指数对急性心肌梗死合并心原性休克患者管理和结局的影响。
Cardiovasc Revasc Med. 2022 Mar;36:34-40. doi: 10.1016/j.carrev.2021.04.028. Epub 2021 Apr 30.
5
Obesity and Outcomes Following Cardiogenic Shock Requiring Acute Mechanical Circulatory Support.肥胖与心源性休克需要急性机械循环支持后的预后
Circ Heart Fail. 2021 Mar;14(3):e007937. doi: 10.1161/CIRCHEARTFAILURE.120.007937. Epub 2021 Mar 12.
6
Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide.肥胖与 COVID-19 结局:当疫情与大流行碰撞。
Mayo Clin Proc. 2020 Jul;95(7):1445-1453. doi: 10.1016/j.mayocp.2020.05.006. Epub 2020 May 19.
7
Disparate effects of obesity on survival and hospitalizations in heart failure with preserved ejection fraction.肥胖对射血分数保留的心力衰竭患者生存及住院情况的不同影响。
Int J Obes (Lond). 2020 Jul;44(7):1543-1545. doi: 10.1038/s41366-020-0579-6. Epub 2020 Apr 20.
8
Cardiorespiratory fitness, muscular strength, and obesity in adolescence and later chronic disability due to cardiovascular disease: a cohort study of 1 million men.青少年时期的心肺健康、肌肉力量和肥胖与心血管疾病导致的后期慢性残疾之间的关系:一项涉及 100 万男性的队列研究。
Eur Heart J. 2020 Apr 14;41(15):1503-1510. doi: 10.1093/eurheartj/ehz774.
9
Epidemiology of Shock in Contemporary Cardiac Intensive Care Units.当代心脏重症监护病房中休克的流行病学
Circ Cardiovasc Qual Outcomes. 2019 Mar;12(3):e005618. doi: 10.1161/CIRCOUTCOMES.119.005618.
10
Outcomes in Cardiogenic Shock from Acute Coronary Syndrome Depending on Severity of Obesity.肥胖严重程度对急性冠状动脉综合征所致心源性休克患者预后的影响。
Am J Cardiol. 2019 Apr 15;123(8):1267-1272. doi: 10.1016/j.amjcard.2019.01.010. Epub 2019 Jan 24.